US HB1098 | 2019-2020 | 116th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 11-3)
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Referred to the House Committee on Foreign Affairs.
Pending: House Foreign Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Referred to the House Committee on Foreign Affairs.
Pending: House Foreign Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Expands reporting requirements related to foreign countries that produce illicit fentanyl and limits assistance to countries that fail to take various actions to combat illegal drug production and trafficking. The President's annual report to Congress on U.S. strategy for controlling international narcotics shall include a section that identifies the countries that are the most significant sources of illicit fentanyl, fentanyl analogues, and precursor chemicals used for producing fentanyl. The report shall also describe the extent to which such a country has cooperated with U.S. efforts to prevent exports of such substances into the United States. The United States shall withhold 50% of the foreign assistance allocated to each identified country for the fiscal year. The Department of the Treasury shall also direct U.S. Executive Directors in each multilateral development bank to vote against making loans or allocating funds to such countries. Both restrictions may be waived if the President certifies that the country has cooperated fully with U.S. anti-drug trafficking efforts or if vital U.S. national interests necessitate such a waiver. The bill also directs the President to identify countries that (1) have not adopted various procedures for countering narcotics production and distribution, or (2) are incapable of prosecuting individuals that manufacture or distribute new types of drugs.
Title
Blocking Deadly Fentanyl Imports Act
Sponsors
Rep. James Sensenbrenner [R-WI] | Rep. Gerald Connolly [D-VA] | Rep. Brian Fitzpatrick [R-PA] | Rep. Guy Reschenthaler [R-PA] |
Rep. Mike Kelly [R-PA] | Rep. Ron Wright [R-TX] | Rep. Lloyd Smucker [R-PA] | Rep. Matthew Cartwright [D-PA] |
Rep. Scott Perry [R-PA] | Rep. Conor Lamb [D-PA] | Rep. Mark Meadows [R-NC] | Rep. Dan Meuser [R-PA] |
Rep. Fred Keller [R-PA] | Rep. John Joyce [R-PA] |
History
Date | Chamber | Action |
---|---|---|
2019-02-07 | House | Referred to the House Committee on Foreign Affairs. |
2019-02-07 | House | Introduced in House |
Same As/Similar To
SB400 (Same As) 2019-02-07 - Read twice and referred to the Committee on Foreign Relations.
Subjects
Congressional oversight
Criminal investigation, prosecution, interrogation
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Foreign aid and international relief
International affairs
Licensing and registrations
Trade restrictions
Criminal investigation, prosecution, interrogation
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Foreign aid and international relief
International affairs
Licensing and registrations
Trade restrictions
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/1098/all-info |
Text | https://www.congress.gov/116/bills/hr1098/BILLS-116hr1098ih.pdf |